Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edwards Lifesciences Corp EW

Healthcare Medical Devices
Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter... see more

Recent & Breaking News (NYSE:EW)

Wall Street Fundamentals Releases New In-Depth Stock Reports on EBAY, ETFC, EW and LEN

Accesswire June 11, 2013

Edwards Lifesciences to Present at the Goldman Sachs and William Blair Conferences

Marketwired June 4, 2013

Edwards Lifesciences Comments on FDA Warning Letter

Marketwired May 29, 2013

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Marketwired May 21, 2013

StockCall Scrutinizes STJ, HOLX, NAVB, EW, and RMD

Accesswire May 17, 2013

Free Research Reports on APOL, EW, TTWO and WX Issued by the Paragon Report

Marketwired May 15, 2013

Edwards Lifesciences' Board Approves New $750 Million Share Repurchase Program

Marketwired May 14, 2013

Edwards Lifesciences Announces CFO Retirement

Marketwired May 14, 2013

Edwards Lifesciences to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference

Marketwired May 8, 2013

Edwards Lifesciences to Webcast Annual Meeting of Stockholders

Marketwired May 7, 2013

Free Research Reports on BRCM, DV, EW and RES Issued by the Bedford Report

Marketwired April 26, 2013

Edwards Lifesciences Reports First Quarter Results

Marketwired April 23, 2013

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2013

Marketwired April 17, 2013

StockCall Early Morning Insight into St. Jude Medical, Hologic, Navidea Biopharma, ResMed, and Edwards Lifesciences

PR Newswire April 16, 2013

Patient Advocate Foundation Launches the Heart Valve CareLine, Providing Individualized Assistance to Patients Experiencing Challenges Accessing Healthcare

PR Newswire March 25, 2013

Perfect Trade Setups, How to Play HIG, EW, CTL and FIS

Marketwired March 12, 2013

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

Marketwired March 11, 2013

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

Marketwired March 10, 2013

Leveraging Results to Drive New Innovation - Research Report on Medtronic, Inc., Edwards Lifesciences, Cyberonics, Inc., HeartWare International and Luxottica Group SpA

PR Newswire March 7, 2013

Edwards Lifesciences to Present at the Citigroup and RBC 2013 Global Healthcare Conferences

Marketwired February 21, 2013